Protocol for study of financial incentives for smoking cessation in pregnancy (FISCP): randomised, multicentre study

Noémi Berlin, Léontine Goldzahl, Florence Jusot, Ivan Berlin, Noémi Berlin, Léontine Goldzahl, Florence Jusot, Ivan Berlin

Abstract

Introduction: Maternal smoking during pregnancy is associated with adverse perinatal and postnatal health outcomes. The efficacy of nicotine replacement therapies in helping pregnant smokers to quit is not clearly demonstrated; therefore new interventions should be proposed and assessed. Financial incentives rewarding abstinence from tobacco smoking is one of the promising options.

Objective: To assess the efficacy of financial incentives on smoking abstinence among French pregnant smokers.

Participants: pregnant smokers aged ≥18 years, smoking at least five manufactured or three roll-your-own cigarettes per day, and pregnant for <18 weeks of amenorrhoea (WA).

Setting: participants will be recruited, included and followed-up at monthly face-to-face visits in 16 maternity wards in France.

Interventions: participants will be randomised to a control or an intervention group. After a predefined quit date, participants in the control group will receive €20 vouchers at the completion of each visit but no financial incentive for smoking abstinence. Participants in the intervention group will be rewarded for their abstinence by vouchers on top of the €20 show-up fee. The amount of reward for abstinence will increase as a function of duration of abstinence to stimulate longer periods of abstinence.

Main outcome measure: complete abstinence from quit date to the last predelivery visit.

Secondary outcome measures: point prevalence abstinence, time to relapse to smoking, birth weight, fetal growth restriction, preterm birth. Main data analysis: outcomes will be analysed on an intention-to-treat (ITT) basis. The ITT population is defined as all randomised smoking pregnant women.

Ethics and dissemination: The research protocol was approved by the ethics committee (Comité de Protection des Personnes, CPP) of the Pitié-Salpêtrière Hospital on 15 May 2015, and Amendment No 1 was approved on 13 July 2015. Results will be presented at scientific meetings and published.

Trial registration number: NCT02606227; Pre-results.

Keywords: financial incentives; pregnant smokers; smoking cessation.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Figures

Figure 1
Figure 1
Payoff tree for both the intervention (contingency management) and control groups.

References

    1. Jusot F, Tubeuf S, Trannoy A. Circumstances and efforts: how important is their correlation for the measurement of inequality of opportunity in health? Health Econ 2013;22:1470–95. 10.1002/hec.2896
    1. Etilé F, Jones AM. Schooling and smoking among the baby boomers—an evaluation of the impact of educational expansion in France. J Health Econ 2011;30:811–31. 10.1016/j.jhealeco.2011.05.002
    1. Bur Y.2012. Proposition pour une nouvelle politique de lutte contre le tabac. .
    1. Jacquat D, Touraine J.2013. Rapport d'information sur l'evaluation des politiques publiques de lutte contre le tabagisme. .
    1. Cour des comptes. Rapport d’évaluation des politiques de lutte contre le tabagisme.
    1. Kopp P. Le coût social des drogues en France. OFDT Note 2015-04. .
    1. Nilsson PM, Hofvendahl S, Hofvendahl E et al. . Smoking in pregnancy in relation to gender and adult mortality risk in offspring: the Helsingborg Birth Cohort Study. Scand J Public Health 2006;34:660–4. 10.1080/14034940600607509
    1. Knopik VS, Maccani MA, Francazio S et al. . The epigenetics of maternal cigarette smoking during pregnancy and effects on child development. Dev Psychopathol 2012;24:1377–90. 10.1017/S0954579412000776
    1. The health consequences of smoking—50 years of progress: a report of the surgeon general, 2014. (accessed 9 Apr 2015).
    1. Buka SL, Shenassa ED, Niaura R. Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: a 30-year prospective study. Am J Psychiatry 2003;160:1978–84. 10.1176/appi.ajp.160.11.1978
    1. Ekblad M, Gissler M, Lehtonen L et al. . Prenatal smoking exposure and the risk of psychiatric morbidity into young adulthood. Arch Gen Psychiatry 2010;67:841–9. 10.1001/archgenpsychiatry.2010.92
    1. Burke H, Leonardi-Bee J, Hashim A et al. . Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics 2012;129:735–44. 10.1542/peds.2011-2196
    1. Oken E, Levitan EB, Gillman MW. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes 2008;32:201–10. 10.1038/sj.ijo.0803760
    1. Berlin I. Retentissement postnatal du tabagisme pendant la grossesse. Collège National des Gynécologues et Obstetriciens Français. Mises à jour en Gynécologie Médicale. 2010:205–10.
    1. Doherty SP, Grabowski J, Hoffman C et al. . Early life insult from cigarette smoke may be predictive of chronic diseases later in life. Biomarkers 2009;14 (Suppl 1):97–101. 10.1080/13547500902965898
    1. Stavrou EP, Baker DF, Bishop JF. Maternal smoking during pregnancy and childhood cancer in New South Wales: a record linkage investigation. Cancer Causes Control 2009;20:1551–8. 10.1007/s10552-009-9400-5
    1. Brooks DR, Mucci LA, Hatch EE et al. . Maternal smoking during pregnancy and risk of brain tumors in the offspring. A prospective study of 1.4 million Swedish births. Cancer Causes Control 2004;15:997–1005. 10.1007/s10552-004-1123-z
    1. Mucci LA, Granath F, Cnattingius S. Maternal smoking and childhood leukemia and lymphoma risk among 1,440,542 Swedish children. Cancer Epidemiol Biomarkers Prev 2004;13:1528–33.
    1. Ferreira J. Pregnancy, maternal tobacco smoking, and early age leukemia in Brazil. Front Oncol 2012;2:151 10.3389/fonc.2012.00151
    1. Enquète national périnatal. (accessed 5 Nov 2015).
    1. Institut national de la statistique et des études économiques, Insee—Population—Statistiques d’état civil sur les naissances en 2010. (accessed 1 Apr 2016).
    1. Lelong N, Kaminski M, Saurel-Cubizolles MJ et al. . Postpartum return to smoking among usual smokers who quit during pregnancy. Eur J Public Health 2001;11:334–9. 10.1093/eurpub/11.3.334
    1. Letourneau AR, Sonja B, Mazure CM et al. . Timing and predictors of postpartum return to smoking in a group of inner-city women: an exploratory pilot study. Birth 2007;34:245–52. 10.1111/j.1523-536X.2007.00177.x
    1. Lauria L, Lamberti A, Grandolfo M. Smoking behaviour before, during, and after pregnancy: the effect of breastfeeding. ScientificWorld Journal 2012;2012:154910 10.1100/2012/154910154910
    1. Jones M, Lewis S, Parrott S et al. . Re-starting smoking in the postpartum period after receiving a smoking cessation intervention: a systematic review. Addiction 2016;111:981–90. 10.1111/add.13309
    1. Stead LF, Perera R, Bullen C et al. . Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012;(11):CD000146 10.1002/14651858.CD000146.pub4
    1. Traitements de Substituts Nicotiniques (TSN) et femmes enceintes—ANSM: Agence nationale de sécurité du médicament et des produits de santé. (accessed 9 Apr 2015).
    1. National Institute for Health and Care Excellence. NICE. Smoking: stopping in pregnancy and after childbirth. (accessed 19 Feb 2016).
    1. Treating Tobacco Use and Dependence: 2008 Update—treating_tobacco_use08.pdf. (accessed 9 Apr 2015).
    1. Wisborg K, Henriksen TB, Jespersen LB et al. . Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol. 2000;96:967–71. 10.1016/S0029-7844(00)01071-1
    1. Kapur B, Hackman R, Selby P et al. . Randomized, double-blind, placebo controlled trial of nicotine replacement therapy in pregnancy. Curr Ther Res Clin Exp 2001;62:274–8. 10.1016/S0011-393X(01)80011-4
    1. Hotham ED, Gilbert AL, Atkinson ER. A randomised-controlled pilot study using nicotine patches with pregnant women. Addict Behav 2006;31:641–8. 10.1016/j.addbeh.2005.05.042
    1. Pollak KI, Oncken CA, Lipkus IM et al. . Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med 2007;33:297–305. 10.1016/j.amepre.2007.05.006
    1. Oncken C, Dornelas E, Greene J et al. . Nicotine gum for pregnant smokers: a randomized controlled trial. Obstet Gynecol 2008;112:859–67. 10.1097/AOG.0b013e318187e1ec
    1. Coleman T, Chamberlain C, Cooper S et al. . Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and metaanalysis. Addiction 2011;106:52–61. 10.1111/j.1360-0443.2010.03179.x
    1. Coleman T, Chamberlain C, Davey M-A et al. . Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2012;(9):CD010078 10.1002/14651858.CD010078
    1. Coleman T, Cooper S, Thornton JG et al. . A randomized trial of nicotine-replacement therapy patches in pregnancy. N Engl J Med 2012;366:808–18. 10.1056/NEJMoa1109582
    1. Berlin I, Grangé G, Jacob N et al. . Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. BMJ 2014;348:g1622 10.1136/bmj.g1622
    1. Coleman T, Chamberlain C, Davey M-A et al. . Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2015;(12):CD010078 10.1002/14651858.CD010078.pub2
    1. Chaloupka FJ, Warner KE. Chapter 29 The economics of smoking. Handb Heal Econ 2000;1:1539–627. 10.1016/S1574-0064(00)80042-6
    1. Cawley J, Ruhm CJ. The economics of risky health behaviors. Handb Heal Econ 2011;2:95–199. 10.1016/B978-0-444-53592-4.00003-7
    1. Grossman M. On the concept of health capital and the demand for health. J Polit Econ 1972;80:223–55. 10.1086/259880
    1. Becker GS, Murphy KM. Theory of rational addiction. J Polit Econ 1988;96:675–700. 10.1086/261558
    1. Grignon M, Reddock J. The effect of interventions targeting tobacco consumption: a review of literature reviews. Quest. d’économie la santé 2012;182:1–8.
    1. Godefroy R. Les taxes sur les cigarettes sont-elles régressives? Économie publique/Public Econ 2003;13:3–28.
    1. Colman GJ, Remler DK. Vertical equity consequences of very high cigarette tax increases: If the poor are the ones smoking, how could cigarette tax increases be progressive? J Policy Anal Manag 2008;27:376–400. 10.1002/pam.20329
    1. Cahill K, Hartmann-Boyce J, Perera R. Incentives for smoking cessation. Cochrane Database Syst Rev 2015;(5):CD004307 10.1002/14651858.CD004307.pub5
    1. Higgins ST, Solomon LJ. Some recent developments on financial incentives for smoking cessation among pregnant and newly postpartum women. Curr Addict Rep 2016;3:9–18. 10.1007/s40429-016-0092-0
    1. Lumley J, Chamberlain C, Dowswell T et al. . Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2009;(3):CD001055 10.1002/14651858.CD001055.pub3
    1. Tappin D, Bauld L, Purves D et al. . Financial incentives for smoking cessation in pregnancy: randomised controlled trial. BMJ 2015;350:h134 10.1136/bmj.h134
    1. Gruber J, Koszegi B. Is addiction ‘rational’? Theory and evidence. Q J Econ 2001;116:1261–303. 10.1162/003355301753265570
    1. Khwaja A, Silverman D. Sloan Frank, Time preference, time discounting, and smoking decisions. J Health Econ 2007;26:927–49. 10.1016/j.jhealeco.2007.02.004
    1. Jusot F, Khlat M. The role of time and risk preferences in smoking inequalities: a population-based study. Addict Behav 2013;38:2167–73. 10.1016/j.addbeh.2012.12.011
    1. Brown H, Adams J. The role of time preference in smoking cessation: a longitudinal analysis of data from the Household Income and Labour Dynamics of Australia survey, 2001–08. Addiction 2013;108:186–92. 10.1111/j.1360-0443.2012.03997.x
    1. Grignon M. An empirical investigation of heterogeneity in time preferences and smoking behaviors. J Socio Econ 2009;38:739–51. 10.1016/j.socec.2009.05.003
    1. Anderson LR, Mellor JM. Predicting health behaviors with an experimental measure of risk preference. J Health Econ 2008;27:1260–74. 10.1016/j.jhealeco.2008.05.011
    1. Gwaltney CJ, Metrik J, Kahler CW et al. . Self-efficacy and smoking cessation: a meta-analysis. Psychol Addict Behav 2009;23:56–66. 10.1037/a0013529
    1. Hamilton KR, Mitchell MR, Wing VC et al. . Choice impulsivity: definitions, measurement issues, and clinical implications. Personal Disord 2015;6:182–98. 10.1037/per0000099
    1. Mitchell SH. Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology 1999;146:455–64. 10.1007/PL00005491
    1. Doran N, Spring B, McChargue D et al. . Impulsivity and smoking relapse. Nicotine Tob Res 2004;6:641–7. 10.1080/14622200410001727939
    1. McCrae RR, Costa PT. Validation of the five-factor model of personality across instruments and observers. J Pers Soc Psychol 1987;52:81–90. 10.1037/0022-3514.52.1.81
    1. Malouff JM, Thorsteinsson EB, Schutte NS. The five-factor model of personality and smoking: a meta-analysis. J Drug Educ 2006;36:47–58. 10.2190/9EP8-17P8-EKG7-66AD
    1. Terracciano A, Costa PT. Smoking and the five-factor model of personality. Addiction 2004;99:472–81. 10.1111/j.1360-0443.2004.00687.x
    1. Inhalateurs électroniques de nicotine. In Rapport de l'OMS (2014). .
    1. ANAES, Agence nationale d'accréditation et d’évaluation en santé. Conférence de consensus. Grossesse et tabac (2004). (accessed 3 Apr 2016).
    1. INPES. Institut national de prévention et d’éducation pour la santé. Grossesse et arrêt du tabac: Accompagner par l’écoute et le dialogue—Les essentiels de l'Inpes—Essentiel_GrossesseArretTabac.pdf. (accessed 3 Apr 2016).
    1. MacArthur C, Newton JR, Knox EG. Effect of anti-smoking health education on infant size at birth: a randomized controlled trial. Br J Obstet Gynaecol 1987;94:295–300. 10.1111/j.1471-0528.1987.tb03094.x
    1. Hebel JR, Fox NL, Sexton M. Dose-response of birth weight to various measures of maternal smoking during pregnancy. J Clin Epidemiol 1988;41:483–9. 10.1016/0895-4356(88)90050-9
    1. Li CQ, Windsor RA, Perkins L et al. . The impact on infant birth weight and gestational age of cotinine-validated smoking reduction during pregnancy. JAMA 1993;269:1519–24. 10.1001/jama.1993.03500120057026
    1. Benjamin-Garner R, Stotts A. Impact of smoking exposure change on infant birth weight among a cohort of women in a prenatal smoking cessation study. Nicotine Tob Res 2013;15:685–92. 10.1093/ntr/nts184
    1. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res 2012;14:75–8. 10.1093/ntr/ntr137
    1. Berlin I, Singleton E. G, Heishman S. J. Validity of the 12-item French version of the Tobacco Craving Questionnaire in treatment-seeking smokers. Nicotine Tob Res 2010;12:500–7. 10.1093/ntr/ntq039
    1. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986;43:289–94. 10.1001/archpsyc.1986.01800030107013
    1. The University of Vermont. Vermont Center on Behavior and Health. (accessed 3 Apr 2016).
    1. Ewing J. A. Detecting alcoholism. The CAGE questionnaire. JAMA 1984;252:1905–7. 10.1001/jama.1984.03350140051025
    1. Dohmen TJ, Falk A, Heckmann JJ et al. . Individual risk attitudes: measurement, determinants, and behavioral consequences. J Eur Econ Assoc 2011;9:522–50. 10.1111/j.1542-4774.2011.01015.x
    1. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 1995;51:768–74. 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>;2-1
    1. Baylé FJ, Bourdel MC, Caci H et al. . Structure factorielle de la traduction française de l’échelle d'impulsivité de Barratt (BIS-10)./Factor structure of the French translation of the Barratt Impulsivity Scale (BIS-10). Can J Psychiatry 2000;45:156–65.
    1. Labs SM, Wurtele SK. Fetal Health Locus of Control scale: development and validation. J Consult Clin Psychol 1986;54:814–19. 10.1037/0022-006X.54.6.814
    1. Hukkanen J, Jacob P, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005;57:79–115. 10.1124/pr.57.1.3
    1. Boffetta P, Hecht S, Gray N et al. . Smokeless tobacco and cancer. Lancet Oncol 2008;9:667–75. 10.1016/S1470-2045(08)70173-6
    1. Marclay F, Saugy M. Determination of nicotine and nicotine metabolites in urine by hydrophilic interaction chromatography-tandem mass spectrometry: potential use of smokeless tobacco products by ice hockey players. J Chromatogr A 2010;1217:7528–38. 10.1016/j.chroma.2010.10.005
    1. Marclay F, Grata E, Perrenoud L et al. . A one-year monitoring of nicotine use in sport: frontier between potential performance enhancement and addiction issues. Forensic Sci Int 2011;213:73–84. 10.1016/j.forsciint.2011.05.026
    1. Nott KH, Vedhara K. The measurement and significance of stressful life events in a cohort of homosexual HIV positive men. AIDS Care 1995;7:55–69. 10.1080/09540129550126966
    1. Boyd KA, Briggs AH, Bauld L et al. . Are financial incentives cost effective to support smoking cessation during pregnancy? Addiction 2016;111:360–70. 10.1111/add.13160

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera